Evaluation of the percutaneous intramyocardial injection for local myocardial treatment

Catheterization and Cardiovascular Interventions

Volumn 53, Issue 2, 2001, Pages 271-276

  Rezaee, Mehrdad ^a,b   Yeung, Alan C ^a,d   Altman, Peter ^b   Lubbe, Dieter ^c   Takeshi, Suzuki ^a   Schwartz, Robert S ^c   Stertzer, Simon ^a   Altman, John D ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BioCardia Inc   (United States)

^c MAYO CLINIC   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Catheter; Growth factors; Local delivery

Indexed keywords

GROWTH FACTOR; SERUM ALBUMIN I 131;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DRUG DELIVERY SYSTEM; HEART LEFT VENTRICLE; ISOTOPE LABELING; NEEDLE; NONHUMAN; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; CARDIOMYOPATHIES; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; FLUOROSCOPY; INJECTIONS; IODINE RADIOISOTOPES; MICROSPHERES; MYOCARDIUM;

EID: 0034964782     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.1164     Document Type: Article

References (16)

1. VEGF administration in chronic myocardial ischemia in pigs
2. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs
3. Therapeutic angiogenesis with basic fibroblast growth factor: Techniques and early results
4. Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis
5. Phase II, multicenter, double-blind, placebo-controlled, dose-finding study for safety, pharmacokinetics, and efficacy of recombinant fibroblast growth factor (rFGF-2) in subjects with coronary artery disease (CAD): FGF-2 Initiating Revascularization Support Trial (FIRST)
6. Intracoronary and intravenous administration of basic fibroblast growth factor: Myocardial and tissue distribution
7. Electromagnetic guidance for catheter-based transendocardial injection: A platform for intramyocardial angiogenesis therapy -Results in normal and ischemic porcine models
8. Images in cardiovascular medicine: Percutaneous myocardial gene transfer of phVEGF-2
9. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis
10. Recombinant fibroblast growth factor-l promotes intima hyperplasia and angiogenesis in arteries in vivo
11. The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: First clinical results
12. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
13. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
14. Quantitative protein precipitation from guanidine hydrochloride-containing solutions by sodium deoxycholate/trichloroacetic acid
15. Feasibility studies of a novel percutaneous device for intramyocardial drug and mammalian cell delivery
16. Tissue and myocardial distribution of intracoronary, intravenous, intrapericardial, and intramyocardial 125i-labeled basic fibroblast growth factor (bFGF) favor intramyocardial delivery